MicroConstants Welcomes Dr. John Marcelletti as Senior Director of Immunology

SAN DIEGO, CALIFORNIA, September 25, 2015 – MicroConstants is pleased to welcome Dr. John Marcelletti to our team as Senior Director of Immunology. “We are excited to bring John into our family. He brings more than 20 years of drug development experience to the table, with many years directing regulated bioanalytical lab operations (GLP and regulated clinical),” added Gilbert N. Lam, President and Chief Scientific Officer of MicroConstants.

MicroConstants is pleased to welcome Dr. John Marcelletti to our team as Senior Director of Immunology. “We are excited to bring John into our family. He brings more than 20 years of drug development experience to the table, with many years directing regulated bioanalytical lab operations (GLP and regulated clinical),” added Gilbert N. Lam, President and Chief Scientific Officer of MicroConstants.

As Senior Director, John will oversee immunology operations at MicroConstants, including development and validation of large molecule drug immunoanalytical methods in support of regulated pharmacokinetic and toxicokinetic (PK/TK) analyses of preclinical and clinical biological samples. He will also direct similar activities concerning drug immunogenicity studies, including methods for antidrug antibodies (ADA) and neutralizing antibodies (NAb). Dr. Marcelletti brings over 15 years of experience involving design and use of biomarker assays (single and multiplex) as pharmacodynamics (PD) and companion diagnostic (CDx) tools for drug development.

Before joining MicroConstants, John was Senior Lab Director at Tandem Labs (LabCorp) from 2012-2015, during which time he directed the firm’s San Diego bioanalytical immunology lab in support of regulated preclinical and clinical pharmacology studies. Prior to that, he held a variety of positions directing translational medicine operations in oncology and autoimmunity, mostly focused on incorporation of biomarkers into clinical studies as PD and CDx tools for drug development. He has also served as a private consultant where he specialized in drug development and precision medicine in preclinical and clinical study designs, bioanalytical issues and medical writing. He is affiliated with the American Association of Immunologists, American College of Rheumatology, and American Association of Pharmaceutical Scientists.

John received his Ph.D from the Department of Immunology and Microbiology, Wayne State University School of Medicine in MI. He also holds an MBA from The Haworth College of Business at Western Michigan University. His bibliography includes 65 scientific publications and patents, primarily in immunology, drug development, and use of biomarkers in precision medicine.

Founded in 1998, MicroConstants is a contract research organization focused on performing regulated bioanalysis, drug metabolism and pharmacokinetic analysis in support of discovery, preclinical and clinical drug development studies. We specialize in method development, validation and sample analysis for small molecules, macromolecules, biomarkers and metabolites. MicroConstants is dedicated to becoming the recognized leader in regulated bioanalysis, drug metabolism and pharmacokinetic analysis.

Please join us in welcoming John Marcelletti to our MicroConstants community!

For more information, contact:

MicroConstants, Inc.
info@microconstants.com
+1 (858) 652-4600